The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Finally! The First Approved Treatment for Morning Sickness in 30 Years

by Dr. Sharon Orrange on April 16, 2013 at 2:06 pm

Big news this week when the FDA announced approval of Diclegis for morning sickness.

What is it? Diclegis is a delayed release tablet that is a mixture of doxylamine succinate and vitamin B6 (pyridoxine HCl). Diclegis is a mixture of an antihistamine and vitamin B6.

Who will use it? The FDA has approved the use of Diclegis for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. It is the only FDA-approved treatment for “morning sickness” in over 30 years.

Does it hurt the baby? Listen up! Diclegis was granted Pregnancy Category A status indicating that results of controlled studies have not shown an increased risk to an unborn baby during pregnancy.

Does it work? Diclegis was approved based on a 15 day trial studying pregnant women during their 7th – 14th week of gestation with nausea and vomiting from pregnancy. Treatment with Diclegis resulted in significantly larger improvement in symptoms compared to placebo.

When can you get it? Diclegis will be available as a combination delayed-release tablet containing 10mg of doxylamine succinate and 10mg of pyridoxine HCL and is expected to hit the market by the end of May 2013.

Dr O.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.